Who owns Crinetics Pharmaceuticals In?
- Ticker: CRNX
- CUSIP Number: 22663k107
Tip: Access positions for across all investors
Analyze quarterly positions in Crinetics Pharmaceuticals In with up to 7 years of data, all consolidated into one spreadsheet
Download as csv

Top investors of Crinetics Pharmaceuticals In stock
Who bought or sold Crinetics Pharmaceuticals In this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
FMR | 14M | $471M | 57% | Mar 2025 |
|
Vanguard Group | 9.3M | $312M | 2% | Mar 2025 |
|
BlackRock | 7.7M | $257M | 2% | Mar 2025 |
|
Wellington Management Company | 6.9M | $231M | -1% | Mar 2025 |
|
Driehaus Capital Management | 6.2M | $209M | 2% | Mar 2025 |
|
T. Rowe Price Associates | 5.4M | $277M | 9% | Dec 2024 |
|
EcoR1 Capital | 4.3M | $219M | 0% | Dec 2024 |
|
Farallon Capital Management | 4.1M | $208M | 251% | Dec 2024 |
|
Henderson Group | 3.4M | $119M | 23% | Mar 2025 |
|
State Street Corporation | 3.3M | $110M | 10% | Mar 2025 |
|
Geode Capital Management | 2.2M | $74M | 4% | Mar 2025 |
|
Jennison Associates | 2.1M | $71M | -22% | Mar 2025 |
|
Paradigm Biocapital Advisors | 1.9M | $65M | 2% | Mar 2025 |
|
Siren | 1.7M | $57M | 5% | Mar 2025 |
|
Vestal Point Capital | 1.5M | $50M | 100% | Mar 2025 |
|
Novo A/S | 1.3M | $43M | 33% | Mar 2025 |
|
Pictet Asset Management Holding SA | 1.0M | $35M | 23% | Mar 2025 |
|
T. Rowe Price Investment Management | 1.0M | $51M | -6% | Dec 2024 |
|
Cormorant Asset Management | 1.0M | $51M | -9% | Dec 2024 |
|
OrbiMed Advisors | 999k | $34M | 0% | Mar 2025 |
|
Franklin Resources | 963k | $32M | -39% | Mar 2025 |
|
Jennifer Ranahan | 920k | $31M | 35% | Mar 2025 |
|
Northern Trust | 857k | $29M | -3% | Mar 2025 |
|
First Light Asset Management | 855k | $29M | -3% | Mar 2025 |
|
Hood River Capital Management | 851k | $44M | 2% | Dec 2024 |
|
Point72 Asset Management | 778k | $26M | -72% | Mar 2025 |
|
Charles Schwab Investment Management | 754k | $25M | -1% | Mar 2025 |
|
Lord, Abbett & Co | 725k | $37M | -3% | Dec 2024 |
|
American Century Companies | 720k | $24M | 51% | Mar 2025 |
|
MPM Oncology Impact Management | 632k | $21M | 2% | Mar 2025 |
|
Bnp Paribas Investment Partners | 611k | $21M | 6% | Mar 2025 |
|
Eventide Asset Management | 609k | $31M | -17% | Dec 2024 |
|
Nuveen | 563k | $19M | 100% | Mar 2025 |
|
Fisher Investments | 559k | $29M | 16% | Dec 2024 |
|
Nuveen Asset Management | 528k | $27M | 3% | Dec 2024 |
|
SG Americas Securities | 522k | $18M | -4% | Mar 2025 |
|
Ikarian Capital | 516k | $26M | 21% | Dec 2024 |
|
Morgan Stanley | 505k | $26M | 100% | Dec 2024 |
|
Ensign Peak Advisors | 503k | $26M | -19% | Dec 2024 |
|
Goldman Sachs Group | 500k | $17M | -31% | Mar 2025 |
|
Affinity Asset Advisors | 460k | $24M | 15% | Dec 2024 |
|
Schonfeld Strategic Advisors | 446k | $23M | -9% | Dec 2024 |
|
Fiera Capital Corporation | 438k | $15M | -4% | Mar 2025 |
|
Ing Investment Management | 389k | $20M | 0% | Dec 2024 |
|
Ubs Global Asset Management Americas | 348k | $12M | 7% | Mar 2025 |
|
Bank of New York Mellon | 345k | $12M | 0% | Mar 2025 |
|
Universal- Beteiligungs- und Servicegesellschaft mbH | 343k | $12M | 2% | Mar 2025 |
|
UBS Group | 316k | $11M | -55% | Mar 2025 |
|
Integral Health Asset Management | 300k | $15M | 0% | Dec 2024 |
|
Rock Springs Capital Management | 294k | $15M | 2% | Dec 2024 |
|
M&G | 282k | $9.6M | 100% | Mar 2025 |
|
Prudential Financial | 277k | $14M | 61% | Dec 2024 |
|
Jpmorgan Chase & Co | 266k | $8.9M | -2% | Mar 2025 |
|
Victory Capital Management | 251k | $8.4M | -11% | Mar 2025 |
|
Bank of America Corporation | 235k | $12M | -15% | Dec 2024 |
|
Qube Research & Technologies | 220k | $11M | -24% | Dec 2024 |
|
Ameriprise Financial | 205k | $6.9M | -42% | Mar 2025 |
|
Deutsche Bank Aktiengesellschaft | 204k | $6.8M | -3% | Mar 2025 |
|
Decheng Capital | 178k | $6.0M | 6% | Mar 2025 |
|
TD Asset Management | 175k | $5.9M | -24% | Mar 2025 |
|
Barclays | 166k | $5.6M | -9% | Mar 2025 |
|
Swiss National Bank | 162k | $5.4M | 2% | Mar 2025 |
|
Citigroup | 150k | $5.0M | 24% | Mar 2025 |
|
Segall Bryant & Hamill | 146k | $4.9M | -3% | Mar 2025 |
|
Walleye Trading Advisors | 146k | $7.5M | -35% | Dec 2024 |
|
New Leaf Venture Partners | 141k | $4.7M | 0% | Mar 2025 |
|
Moody Aldrich Partners | 140k | $4.7M | -3% | Mar 2025 |
|
New York State Common Retirement Fund | 138k | $4.6M | -11% | Mar 2025 |
|
Boothbay Fund Management | 138k | $7.0M | 26% | Dec 2024 |
|
Manufacturers Life Insurance Company | 135k | $4.5M | -10% | Mar 2025 |
|
Rhumbline Advisers | 132k | $4.4M | 6% | Mar 2025 |
|
Longwood Capital Partners | 123k | $6.3M | -7% | Dec 2024 |
|
Duquesne Family Office | 123k | $6.3M | -60% | Dec 2024 |
|
Pier Capital | 113k | $3.8M | 1% | Mar 2025 |
|
Alliancebernstein | 111k | $3.7M | 9% | Mar 2025 |
|
Rafferty Asset Management | 102k | $3.4M | 26% | Mar 2025 |
|
Wells Fargo & Company | 92k | $3.1M | -9% | Mar 2025 |
|
Legal & General Group | 89k | $3.0M | 0% | Mar 2025 |
|
Soleus Capital Management | 85k | $4.3M | 100% | Dec 2024 |
|
Principal Financial Group | 81k | $2.7M | 0% | Mar 2025 |
|
Schroder Investment Management Group | 78k | $2.7M | 164% | Mar 2025 |
|
California State Teachers Retirement System | 76k | $3.9M | 19% | Dec 2024 |
|
Invesco | 70k | $2.3M | -77% | Mar 2025 |
|
Citadel Advisors | 69k | $2.3M | 194% | Mar 2025 |
|
ALPS Advisors | 67k | $2.3M | -10% | Mar 2025 |
|
Susquehanna International | 65k | $3.3M | -25% | Dec 2024 |
|
State of Wisconsin Investment Board | 64k | $2.1M | -15% | Mar 2025 |
|
Mirae Asset Global Etfs Holdings | 59k | $2.1M | 12% | Mar 2025 |
|
Saturn V Capital Management | 59k | $2.0M | 0% | Mar 2025 |
|
NEOS Investment Management | 59k | $2.0M | 2% | Mar 2025 |
|
Tema Etfs | 59k | $2.0M | 2% | Mar 2025 |
|
Intech Investment Management | 57k | $1.9M | 32% | Mar 2025 |
|
Envestnet Asset Management | 57k | $1.9M | -10% | Mar 2025 |
|
State of New Jersey Common Pension Fund D | 56k | $1.9M | 47% | Mar 2025 |
|
Sei Investments | 56k | $2.8M | -1% | Dec 2024 |
|
AWM Investment Company | 55k | $2.8M | 0% | Dec 2024 |
|
ADAR1 Capital Management | 53k | $1.8M | 0% | Mar 2025 |
|
MetLife Investment Advisors | 53k | $2.7M | 18% | Dec 2024 |
|
Exome Asset Management | 51k | $1.7M | 100% | Mar 2025 |
|
Parkman Healthcare Partners | 51k | $2.6M | -34% | Dec 2024 |
|
Woodline Partners | 50k | $2.6M | 100% | Dec 2024 |
|
Natixis Asset Management Advisors | 47k | $1.6M | 2% | Mar 2025 |
|
Macquarie Group | 45k | $1.5M | -1% | Mar 2025 |
|
Corebridge Financial | 45k | $1.5M | 3% | Mar 2025 |
|
Superstring Capital Management | 44k | $1.5M | 100% | Mar 2025 |
|
Standard Life Aberdeen | 43k | $2.2M | 22% | Dec 2024 |
|
First Trust Advisors | 38k | $1.3M | -81% | Mar 2025 |
|
Cinctive Capital Management | 37k | $1.9M | -25% | Dec 2024 |
|
Russell Investments | 34k | $1.7M | -56% | Dec 2024 |
|
Hennion & Walsh Asset Management | 33k | $1.1M | -19% | Mar 2025 |
|
Guggenheim Capital, LLC Managers | 31k | $1.0M | 18% | Mar 2025 |
|
Creative Planning | 30k | $1.0M | 11% | Mar 2025 |
|
Legato Capital Management | 30k | $1.5M | 16% | Dec 2024 |
|
Teachers Retirement System Of The State Of Kentucky | 29k | $972k | -19% | Mar 2025 |
|
HighVista Strategies | 29k | $970k | 0% | Mar 2025 |
|
Pathstone Holdings | 28k | $950k | 39% | Mar 2025 |
|
Aquatic Capital Management | 28k | $1.4M | 100% | Dec 2024 |
|
UBS O'Connor | 28k | $1.4M | 12% | Dec 2024 |
|
Royal Bank of Canada | 27k | $896k | -9% | Mar 2025 |
|
Verition Fund Management | 27k | $887k | 54% | Mar 2025 |
|
Algert Coldiron Investors | 26k | $882k | -9% | Mar 2025 |
|
Gilder, Gagnon, Howe & Co | 25k | $821k | -2% | Mar 2025 |
|
ProShare Advisors | 24k | $806k | -17% | Mar 2025 |
|
Arizona State Retirement System | 24k | $802k | 2% | Mar 2025 |
|
Teacher Retirement System Of Texas | 22k | $753k | -7% | Mar 2025 |
|
ProFund Advisors | 22k | $735k | 30% | Mar 2025 |
|
Handelsbanken Fonder AB | 22k | $731k | 0% | Mar 2025 |
|
Jane Street | 22k | $725k | 192% | Mar 2025 |
|
Sanders Morris Harris | 21k | $646k | 0% | Mar 2025 |
|
Lewis Asset Management | 20k | $671k | 104% | Mar 2025 |
|
HighMark Wealth Management | 20k | $671k | 0% | Mar 2025 |
|
Great-West Life Assurance Company | 19k | $646k | 0% | Mar 2025 |
|
China Universal Asset Management | 19k | $626k | -5% | Mar 2025 |
|
Florida State Board of Administration | 18k | $617k | 0% | Mar 2025 |
|
Assetmark | 18k | $929k | 6% | Dec 2024 |
|
Skandinaviska Enskilda Banken AB | 18k | $608k | 0% | Mar 2025 |
|
Bryce Point Capital | 17k | $611k | 100% | Mar 2025 |
|
Glenmede Trust Company | 17k | $582k | 0% | Mar 2025 |
|
Orion Portfolio Solutions | 17k | $855k | -8% | Dec 2024 |
|
Zurcher Kantonalbank | 15k | $493k | -3% | Mar 2025 |
|
Hsbc Holdings | 14k | $436k | 7% | Mar 2025 |
|
Springbok Capital Management | 13k | $435k | 100% | Mar 2025 |
|
DekaBank Deutsche Girozentrale | 11k | $388k | 0% | Mar 2025 |
|
Bnp Paribas Arbitrage, Snc | 11k | $351k | -31% | Mar 2025 |
|
Stifel Financial | 9.9k | $506k | -1% | Dec 2024 |
|
EntryPoint Capital | 9.4k | $315k | 100% | Mar 2025 |
|
Summit Investment Advisors | 9.2k | $308k | 0% | Mar 2025 |
|
Public Employees' Retirement Association of Colorado | 9.0k | $302k | 0% | Mar 2025 |
|
Taikang Asset Management | 8.5k | $435k | 0% | Dec 2024 |
|
Cibc World Markets | 8.2k | $420k | 100% | Dec 2024 |
|
Keybank National Association | 8.1k | $273k | -13% | Mar 2025 |
|
Cresset Asset Management | 7.2k | $369k | -20% | Dec 2024 |
|
Martingale Asset Management | 6.7k | $225k | -70% | Mar 2025 |
|
Who sold out of Crinetics Pharmaceuticals In?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
First Turn Management | Dec 2024 | 453k | $23M |
Dimensional Fund Advisors | Sep 2024 | 392k | $20M |
Stempoint Capital | Dec 2024 | 317k | $16M |
Perceptive Advisors | Dec 2024 | 185k | $9.4M |
Nicholas Investments Partners | Dec 2024 | 127k | $6.5M |
Man Group | Sep 2024 | 100k | $5.1M |
AH Lisanti Capital Growth | Dec 2024 | 83k | $4.2M |
CastleArk Management | Dec 2024 | 78k | $4.0M |
Adage Capital Partners GP | Dec 2024 | 65k | $3.3M |
Trexquant Investment | Sep 2024 | 63k | $3.2M |
Artia Global Partners | Dec 2024 | 46k | $2.3M |
Squarepoint Ops | Sep 2024 | 35k | $1.8M |
Allianz Asset Management | Dec 2024 | 16k | $839k |
Calamos Advisors | Dec 2024 | 14k | $736k |
Peak6 | Dec 2024 | 10k | $511k |
D. E. Shaw & Co | Dec 2024 | 9.9k | $505k |
Brevan Howard Capital Management | Dec 2024 | 9.8k | $500k |
Advantage Alpha Capital Partners | Sep 2024 | 8.6k | $442k |